Moyamoya Syndrome in Patients With Down Syndrome and Acute Lymphoblastic Leukemia
- PMID: 40916063
- DOI: 10.1002/pbc.32045
Moyamoya Syndrome in Patients With Down Syndrome and Acute Lymphoblastic Leukemia
Abstract
Moyamoya syndrome (MMS) is a chronic vasculopathy characterized by progressive stenosis of intracerebral arteries, leading to an increased risk of stroke. Children with Down syndrome (DS) are at an increased risk of co-occurring medical conditions, including MMS and leukemia. We report four patients with the triad of DS, MMS, and acute lymphoblastic leukemia (ALL). Two patients had a diagnosis of MMS prior to developing ALL, whereas two were diagnosed with MMS during ALL therapy. This series highlights the need to remain cognizant of MMS in patients with DS and ALL, particularly in those with acute neurologic changes.
Keywords: ALL; Down syndrome; moyamoya.
© 2025 Wiley Periodicals LLC.
References
-
- C. Rupareliya and F. Lui, “Moyamoya Disease,” in StatPearls (StatPearls Publishing, 2023), https://www.ncbi.nlm.nih.gov/books/NBK535455/.
-
- C. Han, J. Chen, S. Gao, and L. Duan, “Moyamoya Disease in Asia,” Neurology Asia 7, no. 3 (2012): 175–181.
-
- S. Lee, M. J. Rivkin, A. Kirton, G. deVeber, and J. Elbers, “Moyamoya Disease in Children: Results from the International Pediatric Stroke Study,” Journal of Child Neurology 32, no. 11 (2017): 924–929, https://doi.org/10.1177/0883073817718730.
-
- F. Akhtar and S. R. A. Bokhari, “Down Syndrome,” in StatPearls (StatPearls Publishing 2023), https://www.ncbi.nlm.nih.gov/books/NBK526016/.
-
- Centers for Disease Control and Prevention, Data and Statistics on Birth Defects (CDC, 2024), https://www.cdc.gov/birth‐defects/data‐research/facts‐stats/index.html.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
